CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record; the references it cites are not checked yet.

Transient elastography for the prediction of oxaliplatin-associated liver injury in colon cancer patients: a preliminary analysis

Oki, Eiji, Kakeji, Yoshihiro, Taketomi, Akinobu, Yamashita, Yoichi, Ohgaki, Kippei, Harada, Noboru, Iguchi, Tomohiro, Shibahara, Kotaro, Sadanaga, Noriaki, Morita, Masaru, Maehara, Yoshihiko·2008·Journal of Gastrointestinal Cancer
DOI 10.1007/s12029-009-9063-1
Open this paper in CoChat — free account

Abstract

Objective The prognosis of advanced colon cancer has improved significantly over the last decade since new chemotherapy regimens including oxaliplatin have been developed. However, oxaliplatin-induced liver injury and characterized hepatic hemostatic status can occur after chemotherapy. The assessment of this type of liver injury is often difficult. Methods Elastography (Fibroscan) was used to evaluate liver injury in five cases before and after 5-FU, leucovorin, and oxaliplatin combination (FOLFOX) treatment. Results A clear change was observed in the stiffness of liver after chemotherapy within 48 h, and the hepatic stiffness was normalized in most cases after 2 weeks. Among the five patients, one patient showed aberrant elevation after a FOLFOX treatment, and the patient showed liver injury pathologically. Conclusion Elastography is a good tool for evaluating hepatic injury after FOLFOX treatment.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12029-009-9063-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists haven’t been fetched yet

Cited by 13

Research works printed but not linked: 15

  1. Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg. 2006;202:199–200. doi:10.1016/j.jamcollsurg.2005.09.010. · DOI
  2. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–466. doi:10.1093/annonc/mdh095. · DOI
  3. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–2072. doi:10.1200/JCO.2005.05.3074. · DOI
  4. Arotcarena R, Cales V, Berthelemy P, Parent Y, Malet M, Etcharry F, et al. Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol. 2006;30:1313–1316. doi:10.1016/S0399-8320(06)73542-4. · DOI
  5. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006;45:230–235. doi:10.1016/j.jhep.2006.04.006. · DOI
  6. Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol. 2006;18:1321–1325. doi:10.1097/01.meg.0000243884.55562.37. · DOI
  7. Verveer C, de Knegt RJ. Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology. Scand J Gastroenterol Suppl. 2006;243:85–88. doi:10.1080/00365520600664359. · DOI
  8. Berends MA, Snoek J, de Jong EM, Van Krieken JH, de Knegt RJ, van Oijen MG, et al. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. Liver Int. 2007;27:639–645. doi:10.1111/j.1478-3231.2007.01489.x. · DOI
  9. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408. doi:10.1136/gut.2005.069153. · DOI
  10. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol. 2007;46:628–634. doi:10.1016/j.jhep.2006.11.010. · DOI
  11. Laharie D, Zerbib F, Adhoute X, Boue-Lahorgue X, Foucher J, Castera L, et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn’s disease patients treated with methotrexate. Aliment Pharmacol Ther. 2006;23:1621–1628. doi:10.1111/j.1365-2036.2006.02929.x. · DOI
  12. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713. doi:10.1016/j.ultrasmedbio.2003.07.001. · DOI
  13. Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44:1511–1517. doi:10.1002/hep.21420. · DOI
  14. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274–286. doi:10.1002/bjs.5719. · DOI
  15. Sebagh M, Plasse M, Levi F, Adam R. Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity? Ann Oncol. 2005;16:331. author reply 332–333. doi:10.1093/annonc/mdi040. · DOI

Metadata

Authors
Oki, E., Kakeji, Y., Taketomi, A., Yamashita, Y., Ohgaki, K., Harada, N., Iguchi, T., Shibahara, K., Sadanaga, N., Morita, M., & Maehara, Y.
Venue
Journal of Gastrointestinal Cancer
Publisher
Springer Science and Business Media LLC
Published
2008-03
Volume
39
Issue
1-4
Pages
82-85
ISSN
  • 1941-6628
  • 1941-6636
DOI
10.1007/s12029-009-9063-1
Cited by
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review